The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Donor Selection

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Donor Selection


High impact information on Donor Selection


Biological context of Donor Selection


Associations of Donor Selection with chemical compounds

  • Donor selection criteria continue to expand, focusing most recently on the possibility of exclusion due to intranasal cocaine use and, in the US, due to incarceration for more than 72 hours [12].
  • After donor screening and preservation in glycerol 85%, the skin can be stored in a Skin Bank. Glycerol at this concentration has a bacteriostatic effect after certain time of preservation [13].
  • The historic and potential future impacts on Transfusion Medicine and Science in the UK--from donor selection to component processing--are summarised, and put in a global setting [14].

Gene context of Donor Selection

  • These data support the notion that certain HLA differences do not affect the clinical outcome of UCB transplants and indicate that the expensive and time consuming molecular typing of HLA-C and DQB1 loci might be avoided for UCB donor selection [15].
  • Donor selection was based on serologic typing for HLA class I and high resolution oligotyping for HLA-DRB1-DRB5, and HLA-DQB1 [16].
  • However, unrelated donor selection generally relies on matching only for HLA-A, -B and -DR antigens without considering potential incompatibility for other HLA loci, such as HLA-C, -DQ and -DP [17].
  • Our results indicate that Chl1p participates in the process of donor selection and are consistent with a model in which Chl1p helps establish an intrinsic bias in donor preference [18].
  • Prospective genomic typing for the HA-1 alleles will improve donor selection and identify HLA-A*0201-positive recipients with a high risk for HA-1-induced GvHD [19].

Analytical, diagnostic and therapeutic context of Donor Selection


  1. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group. Alter, H.J., Epstein, J.S., Swenson, S.G., VanRaden, M.J., Ward, J.W., Kaslow, R.A., Menitove, J.E., Klein, H.G., Sandler, S.G., Sayers, M.H. N. Engl. J. Med. (1990) [Pubmed]
  2. Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. Stevens, C.E., Taylor, P.E., Pindyck, J., Choo, Q.L., Bradley, D.W., Kuo, G., Houghton, M. JAMA (1990) [Pubmed]
  3. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone. Nademanee, A., Schmidt, G.M., Parker, P., Dagis, A.C., Stein, A., Snyder, D.S., O'Donnell, M., Smith, E.P., Stepan, D.E., Molina, A. Blood (1995) [Pubmed]
  4. Transplantation of corneal tissue from donors with diseases of the central nervous system. Hogan, R.N., Cavanagh, H.D. Cornea (1995) [Pubmed]
  5. Alpha2p controls donor preference during mating type interconversion in yeast by inactivating a recombinational enhancer of chromosome III. Szeto, L., Fafalios, M.K., Zhong, H., Vershon, A.K., Broach, J.R. Genes Dev. (1997) [Pubmed]
  6. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Flomenberg, N., Baxter-Lowe, L.A., Confer, D., Fernandez-Vina, M., Filipovich, A., Horowitz, M., Hurley, C., Kollman, C., Anasetti, C., Noreen, H., Begovich, A., Hildebrand, W., Petersdorf, E., Schmeckpeper, B., Setterholm, M., Trachtenberg, E., Williams, T., Yunis, E., Weisdorf, D. Blood (2004) [Pubmed]
  7. Role of alpha2 protein in donor locus selection during mating type interconversion. Szeto, L., Broach, J.R. Mol. Cell. Biol. (1997) [Pubmed]
  8. Platelet transfusion therapy for alloimmunized patients: selective mismatching for HLA B12, an antigen with variable expression on platelets. Schiffer, C.A., O'Connell, B., Lee, E.J. Blood (1989) [Pubmed]
  9. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests. Brand, A., van Leeuwen, A., Eernisse, J.G., van Rood, J.J. Blood (1978) [Pubmed]
  10. HLA-DRB4 genotyping by PCR-RFLP: diversity in the associations between HLA-DRB4 and DRB1 alleles. Naruse, T.K., Ando, R., Nose, Y., Kagiya, M., Ando, H., Kawata, H., Nabeya, N., Isshiki, G., Inoko, H. Tissue Antigens (1997) [Pubmed]
  11. The search for HLA-compatible bone marrow donors. Procedure currently used in the Institute of Hematology and Blood Transfusion, Prague. Cukrová, V., Loudová, M., Matĕjková, E., Dolezalová, L., Srámková, I., Korínková, P., Starý, J., Vítek, A. Folia Biol. (Praha) (1996) [Pubmed]
  12. Interactions between science, government and media on selection and testing of donors. Sazama, K. Vox Sang. (1998) [Pubmed]
  13. Sterilization of skin allografts by ionizing radiation. Bourroul, S.C., Herson, M.R., Pino, E., Matho, M.B. Cell. Mol. Biol. (Noisy-le-grand) (2002) [Pubmed]
  14. The impact of variant CJD on transfusion practices in the UK. Boulton, F. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. (2003) [Pubmed]
  15. HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants. Elia, L., Arcese, W., Torello, M., Iori, A.P., Guglielmi, C., Perrone, M.P., Screnci, M., Sprovieri, T., Rapanotti, M.C., Cimino, G. Haematologica (1999) [Pubmed]
  16. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Keever-Taylor, C.A., Passweg, J., Kawanishi, Y., Casper, J., Flomenberg, N., Baxter-Lowe, L.A. Bone Marrow Transplant. (1997) [Pubmed]
  17. Factors influencing the outcome of bone marrow transplants using unrelated donors. Madrigal, J.A., Scott, I., Arguello, R., Szydlo, R., Little, A.M., Goldman, J.M. Immunol. Rev. (1997) [Pubmed]
  18. Mutations affecting donor preference during mating type interconversion in Saccharomyces cerevisiae. Weiler, K.S., Szeto, L., Broach, J.R. Genetics (1995) [Pubmed]
  19. Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR. Wilke, M., Pool, J., den Haan, J.M., Goulmy, E. Tissue Antigens (1998) [Pubmed]
  20. Evaluation of serological screening of cadaveric sera for donor selection for cornea transplantation. Heim, A., Wagner, D., Rothämel, T., Hartmann, U., Flik, J., Verhagen, W. J. Med. Virol. (1999) [Pubmed]
WikiGenes - Universities